The Gastrointestinal Drugs Market region analysis reveals significant geographic variations in disease epidemiology, treatment practices, healthcare infrastructure, regulatory requirements, and market access conditions affecting pharmaceutical company strategies. North American markets demonstrate high adoption rates for innovative biologics and specialty pharmaceuticals driven by...